Investigational EGFR-targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational EGFR-targeted therapy, covering 2024-05-09 to 2024-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma [Phase 2]